Prognostic Benefit of Beta-blockers After Acute Coronary Syndrome With Preserved Systolic Function. Still Relevant Today?

This publication has 30 references indexed in Scilit:

• 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction
  Circulation, 2013
• ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
  European Heart Journal, 2012
• 2012 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction (Updating the 2007 Guideline and Replacing the 2011 Focused Update)
  Circulation, 2012
• ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)
  European Heart Journal, 2011
• Six-Year Follow-up of the Norwegian Multicenter Study on Timolol after Acute Myocardial Infarction
  New England Journal of Medicine, 1985
• Long-term treatment with metoprolol after myocardial infarction: Effect on 3 year mortality and morbidity
  JACC, 1985
• Beta blockade during and after myocardial infarction: An overview of the randomized trials
  Progress in Cardiovascular Diseases, 1985
• The β-Blocker Heart Attack Trial
  JAMA, 1981
• EFFECT ON MORTALITY OF METOPROLOL IN ACUTE MYOCARDIAL INFARCTION
  The Lancet, 1981
• Timolol-Induced Reduction in Mortality and Reinfarction in Patients Surviving Acute Myocardial Infarction
  New England Journal of Medicine, 1981